Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Acquisitions (2023 - 2026)

GE HealthCare Technologies posted quarterly Acquisitions of $2.3 billion for Q1 2026, up 753.9% year-on-year from $269.0 million in Q1 2025, and up 2220.2% on a QoQ basis from $99.0 million in Q4 2025.

GE HealthCare Technologies (GEHC) has 4 years of Acquisitions data on file, last reported at $2.3 billion in Q1 2026.

  • For the quarter ending Q1 2026, Acquisitions rose 753.9% year-over-year to $2.3 billion; the trailing twelve-month figure through Mar 2026 stood at $2.4 billion (up 313.4% YoY), and the FY2025 full-year result was $378.0 million, up 20.77% from the prior year.
  • Acquisitions for Q1 2026 stood at $2.3 billion, up from $99.0 million in the prior quarter.
  • Across five years, Acquisitions topped out at $2.3 billion in Q1 2026 and bottomed at $10.0 million in Q2 2025.
  • The 4-year median for Acquisitions is $113.0 million (2023), against an average of $391.9 million.
  • The widest annual swing landed in 2024, when Acquisitions soared 1195.0%; it then slumped 96.14% in 2025.
  • A 4-year view of Acquisitions shows it stood at $20.0 million in 2023, then soared by 170.0% to $54.0 million in 2024, then soared by 83.33% to $99.0 million in 2025, then soared by 2220.2% to $2.3 billion in 2026.
  • The last three Acquisitions figures came in at $2.3 billion (Q1 2026), $99.0 million (Q4 2025), and $10.0 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 22.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 523.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -268.10 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 2.30 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.30 Bn
Dec 31, 2025 99.00 Mn
Jun 30, 2025 10.00 Mn
Mar 31, 2025 269.00 Mn
Dec 31, 2024 54.00 Mn
Jun 30, 2024 259.00 Mn
Jun 30, 2023 20.00 Mn
Mar 31, 2023 127.00 Mn